Press Releases

All Releases
Yield10 Bioscience Announces First Quarter 2018 Financial Results
May 10, 2018

WOBURN, Mass. , May 10, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today reported financial results for the three months ended March 31, 2018 .

Yield10 Bioscience to Host Webcast of its First Quarter 2018 Conference Call
April 30, 2018

WOBURN, Mass. , April 30, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a Company developing new  technologies to achieve step-change improvements in crop yield that enhance global food security, announced today that the Company plans to release its first quarter 2018 financial

Yield10 Bioscience Announces Plans for its 2018 Field Test Program
April 24, 2018
WOBURN, Mass. , April 24, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today announced plans for its 2018 Field Test Program.
Yield10 Bioscience to Present at The MicroCap Conference
April 3, 2018
  WOBURN, Mass. – April 3, 2018 – Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, announced today that Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will be
Yield10 Bioscience to Present at the Inaugural LD Micro Virtual Conference
March 1, 2018

WOBURN, Mass. Mar. 1, 2018 Yield10 Bioscience, Inc. (NASDAQ: YTEN), a company focused on developing new technologies to achieve step-change improvements to crop yield to enhance global food security, announced today that Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield 10, will be presenting at the LD Micro Virtual Conference on Tuesday, March 6, 2018 at 12:30 pm EST/3:30 pm PT. 

Yield10 Bioscience to Host Webcast of its 2017 Year-end Conference Call
February 28, 2018
WOBURN, Mass. , Feb. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience,Inc. (NASDAQ: YTEN ) announced today that the Company plans to release its fourth quarter and full year 2017 financial results and host a conference call with management after market close on Thursday, March 8, 2018 .
Yield10 Bioscience Announces Closing of $14.5 Million Public Offering
December 21, 2017
WOBURN, Mass. , Dec. 21, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today announced the closing of an underwritten public offering of units for gross proceeds of $14.5 million , which includes the full exercise of the underwriter's over-allotment option to purchase additional
Yield10 Bioscience Announces Pricing of $12.6 Million Public Offering
December 19, 2017
WOBURN, Mass. , Dec. 19, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today announced the pricing of an underwritten public offering of units for gross proceeds of $12.6 million , prior to deducting underwriting discounts and commissions and offering expenses payable by Yield10
Yield10 Bioscience CSO Dr. Kristi Snell to Present at CanolaWeek 2017
December 7, 2017
WOBURN, Mass. , Dec. 07, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced that CSO Kristi Snell , Ph.D., will be presenting today on a panel being held at the CanolaWeek 2017 conference.  Dr. Snell's presentation is titled "Technology for increasing seed yield and oil
Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders
November 29, 2017
WOBURN, Mass. , Nov. 29, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that the Special Meeting of Stockholders scheduled for today to vote on a proposal to decrease the number of shares authorized has been adjourned to December 27, 2017 at 11:30 am ET at 19
Yield10 Bioscience Announces Third Quarter 2017 Financial Results
November 9, 2017
WOBURN, Mass. , Nov. 09, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today reported financial results for the three and nine months ended September 30, 2017 . "Over the course of 2017 we have focused on generating proof points in key crops for our C3003 yield trait gene," said
Yield10 Bioscience to Host Webcast of its Third Quarter 2017 Conference Call
November 6, 2017
WOBURN,Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that the Company plans to release its third quarter 2017 financial results and host a conference call with management after market close on Thursday, November 9, 2017 .   Shareholders will
Displaying 21 - 40 of 76